93 related articles for article (PubMed ID: 29618765)
1. Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS).
Kim JE; Choi J; Park J; Park C; Lee SM; Park SE; Song N; Chung S; Sung H; Han W; Lee JW; Park SK; Kim MK; Noh DY; Yoo KY; Kang D; Choi JY
Pharmacogenomics J; 2018 Sep; 18(5):633-645. PubMed ID: 29618765
[TBL] [Abstract][Full Text] [Related]
2. The associations between immunity-related genes and breast cancer prognosis in Korean women.
Choi J; Song N; Han S; Chung S; Sung H; Lee JY; Jung S; Park SK; Yoo KY; Han W; Lee JW; Noh DY; Kang D; Choi JY
PLoS One; 2014; 9(7):e103593. PubMed ID: 25075970
[TBL] [Abstract][Full Text] [Related]
3. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
Priyadarshini R; Raj GM; Kayal S; Ramesh A; Shewade DG
J Clin Pharm Ther; 2019 Apr; 44(2):188-196. PubMed ID: 30637776
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Park S; Shimizu C; Shimoyama T; Takeda M; Ando M; Kohno T; Katsumata N; Kang YK; Nishio K; Fujiwara Y
Breast Cancer Res Treat; 2006 Sep; 99(1):9-17. PubMed ID: 16752223
[TBL] [Abstract][Full Text] [Related]
5. OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
Li XP; Lan JY; Liu DQ; Zhou H; Qian MM; Wang WW; Yang M
Gene; 2018 Apr; 651():161-165. PubMed ID: 29409738
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis.
Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Expósito-Ruiz M; Calleja-Hernández MÁ
Surg Oncol; 2017 Dec; 26(4):473-482. PubMed ID: 29113667
[TBL] [Abstract][Full Text] [Related]
7. ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.
Kim HJ; Im SA; Keam B; Ham HS; Lee KH; Kim TY; Kim YJ; Oh DY; Kim JH; Han W; Jang IJ; Kim TY; Park IA; Noh DY
Cancer Sci; 2015 Jan; 106(1):86-93. PubMed ID: 25410489
[TBL] [Abstract][Full Text] [Related]
8. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.
Tandia M; Mhiri A; Paule B; Saffroy R; Cailliez V; Noé G; Farinotti R; Bonhomme-Faivre L
Cancer Chemother Pharmacol; 2017 Apr; 79(4):759-766. PubMed ID: 28289864
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
De Mattia E; Toffoli G; Polesel J; D'Andrea M; Corona G; Zagonel V; Buonadonna A; Dreussi E; Cecchin E
Pharmacogenet Genomics; 2013 Oct; 23(10):549-57. PubMed ID: 24018773
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
Müller PJ; Dally H; Klappenecker CN; Edler L; Jäger B; Gerst M; Spiegelhalder B; Tuengerthal S; Fischer JR; Drings P; Bartsch H; Risch A
Int J Cancer; 2009 Apr; 124(7):1669-74. PubMed ID: 19107936
[TBL] [Abstract][Full Text] [Related]
11. Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
Januchowski R; Zawierucha P; Ruciński M; Andrzejewska M; Wojtowicz K; Nowicki M; Zabel M
Biomed Pharmacother; 2014 May; 68(4):447-53. PubMed ID: 24814220
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia.
Yamakawa Y; Hamada A; Nakashima R; Yuki M; Hirayama C; Kawaguchi T; Saito H
Ther Drug Monit; 2011 Apr; 33(2):244-50. PubMed ID: 21311410
[TBL] [Abstract][Full Text] [Related]
13. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcaide E; Castillo-Portellano L; Calleja-Hernández MÁ
Pharmacol Res; 2016 Jun; 108():111-118. PubMed ID: 27137881
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes.
Angelini S; Botticelli A; Onesti CE; Giusti R; Sini V; Durante V; Strigari L; Gentile G; Cerbelli B; Pellegrini P; Sgroi V; Occhipinti M; DI Pietro FR; Rossi A; Simmaco M; Mazzuca F; Marchetti P
Anticancer Res; 2017 May; 37(5):2633-2639. PubMed ID: 28476838
[TBL] [Abstract][Full Text] [Related]
15. Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy.
Afsar NA; Haenisch S; Mateen A; Usman A; Ufer M; Ahmed KZ; Ahmad HR; Cascorbi I
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):570-6. PubMed ID: 20102361
[TBL] [Abstract][Full Text] [Related]
16. Influence of ABCB1 genetic variants in breast cancer treatment outcomes.
Chaturvedi P; Tulsyan S; Agarwal G; Lal P; Agarwal S; Mittal RD; Mittal B
Cancer Epidemiol; 2013 Oct; 37(5):754-61. PubMed ID: 23707158
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis.
Campa D; Müller P; Edler L; Knoefel L; Barale R; Heussel CP; Thomas M; Canzian F; Risch A
Int J Cancer; 2012 Dec; 131(12):2920-8. PubMed ID: 22473764
[TBL] [Abstract][Full Text] [Related]
18. Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients.
Chen J; Ying X; Zhang L; Xiang X; Xiong J
Wien Klin Wochenschr; 2017 Jun; 129(11-12):420-426. PubMed ID: 28074308
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
Huang Y
Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]